To view this email as a web page, click here.
 
CANCER UPDATE
 
New cancer biosimilar could net major sales
A new biosimilar to the cancer drug Herceptin, which raked in $2.5 billion in United States sales last year, is expected to produce blockbuster sales.
Read more
ADVERTISEMENT
 
FDA approves breakthrough cancer gene test
FDA approved a new cancer biomarker test that can detect genetic mutations in 324 genes and 2 genomic signatures in tumors.
Find out more
 
FDA issues warning over marijuana products claiming cancer cure
FDA warns 4 companies that claim that their products containing cannabidiol can treat or cure cancer.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.